Every Form 4 that Maximus (MMS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MMS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MMS filings page.
MAXIMUS, INC. director Jan Madsen reported an open-market sale of 742 shares of Common Stock at $72.25 per share. The transaction took place on March 17, 2026 and was made under a Rule 10b5-1 trading plan adopted on September 14, 2024.
Following this sale, Madsen directly holds 20,794.822 shares of MAXIMUS Common Stock. A 10b5-1 trading plan means the sale was pre-scheduled in advance, which typically indicates a routine approach to liquidity rather than a discretionary trade based on recent company developments.
Madsen Jan reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director Jan Madsen received an equity grant of 3,215 shares of Common Stock in the form of restricted stock units on March 10, 2026. These RSUs vest one year from the grant date, reflecting routine director compensation rather than an open-market purchase.
Madsen elected to defer receipt of the underlying common stock until service on the board ends. Following this grant, direct holdings reported in Common Stock total 21,536.822 shares, which include 65.219 dividend-equivalent rights accrued on previously awarded RSUs.
HALEY JOHN J reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director John J. Haley received an equity grant of 7,009 restricted stock units, a form of stock-based compensation. These RSUs vest one year from the grant date, and he has elected to defer receiving the common shares until his service on the board ends.
Following this grant, he holds 47,115.951 shares of common stock directly. He also has indirect holdings of 71,132 shares through the John J. Haley Grantor Retained Annuity Trust Seven and 32,764 shares through the John J. Haley Grantor Retained Annuity Trust Eight. The position includes 135.462 dividend equivalent rights that vest alongside earlier RSU awards.
Altman Anne K. reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director Anne K. Altman reported receiving an equity award of 3,062 shares of Common Stock at no cash cost, characterized as a grant or award. This represents restricted stock units that vest one year from the grant date and include 13.83 dividend-equivalent rights tied to earlier RSU awards.
After this grant, Altman directly holds a total of 35,141.897 shares. The transaction is compensation-related rather than an open-market purchase or sale, so it reflects routine director remuneration instead of a change in personal trading stance.
Warren Michael J. reported acquisition or exercise transactions in this Form 4 filing.
MAXIMUS, INC. director Michael J. Warren reported an award of 2,246 shares of Common Stock in the form of restricted stock units. These RSUs vest one year from the grant date, effectively adding to his equity-based compensation. Following this award and prior dividend-related adjustments, he holds 17,839.316 shares directly, reflecting both granted units and shares accumulated through dividend equivalents and reinvestment.
MAXIMUS, INC. director Gayathri Rajan received an equity award of 2,246 shares of common stock in the form of restricted stock units that vest one year from the March 10, 2026 grant date. Following this grant, Rajan directly holds a total of 16,704.698 common shares, including dividend-equivalent rights and shares acquired through dividend reinvestment.
MAXIMUS, INC. director Richard A. Montoni reported an indirect disposition of common stock through a bona fide gift. On February 27, 2026, a trust associated with him transferred 7,000 shares of common stock as a gift to a family member at no price. Following this transaction, the trust’s indirect holdings stood at 45,500 common shares.
MAXIMUS, INC. director Richard A. Montoni reported an indirect disposition of 3,000 shares of common stock through a bona fide gift. The shares were held in trust and were gifted to a charitable donor advised fund at no stated price. Following this gift transfer, indirect holdings reported for this trust-related position total 52,500 shares of common stock.
Trusts associated with MAXIMUS, INC. director John J. Haley reported bona fide gifts of 32,764 shares of common stock each on February 18, 2026, at a reported price of $0.00 per share. After these transactions, Haley reports 39,971.489 shares held directly and additional indirect holdings through another trust.
Maximus, Inc. CEO and President Bruce Caswell reported open-market purchases of company common stock. On February 10, 2026, he bought 152 shares at a weighted average price of $76.92, 1,332 shares at $78.22, and 1,691 shares at $78.77. Following these transactions, he directly beneficially owned 328,013.285 shares of Maximus common stock.
Maximus, Inc. director John J. Haley reported non-cash transfers of company stock involving personal and trust holdings. On 02/10/2026, he executed two bona fide gift transfers of Maximus common stock totaling 32,764 shares each at a stated price of $0 per share, moving shares between direct ownership and the John J. Haley Revocable Trust.
Following these transactions, Haley directly held 39,971.489 shares of Maximus common stock and indirectly held 32,764 shares through the revocable trust and 71,132 shares through the John J. Haley Grantor Retained Annuity Trust Seven. A footnote explains that 32,764 shares previously held by a separate annuity trust (Trust Six) were transferred back to Haley as an annuity payment in an exempt transaction under Rule 16a-13.
Maximus, Inc. Chief Financial Officer David Mutryn reported an open-market purchase of company stock. On February 9, 2026, he bought 1,000 shares of Maximus common stock at a price of $75.625 per share. After this transaction, he directly owned 40,036.754 shares of Maximus common stock.
Maximus, Inc. CEO and President Bruce Caswell, who also serves as a director, filed an amended Form 4/A updating his direct ownership of Maximus common stock. On December 2, 2025, he received 96,187.385 shares at a price of $0 upon the release of performance stock units granted on November 25, 2022, including 2,973.815 shares from dividend equivalent rights.
On the same date, 47,276.1 shares were surrendered at $86.51 to cover withholding taxes related to the PSU release. Following these transactions and a downward adjustment of 1.515 shares to correct a clerical error, Caswell directly owned 324,838.285 shares of Maximus common stock. The amendment was filed to correct an administrative error that had caused under-reporting of his prior transactions and beneficial ownership.
Maximus, Inc. CEO and President David Mutryn reported equity transactions in the company’s common stock. On 12/02/2025, he acquired 13,391.387 shares at $0 when previously granted performance stock units vested, including 414.003 shares from dividend equivalent rights. On the same date, he surrendered 39,036.754 shares at $86.51 to cover withholding taxes tied to this vesting. After these transactions, he continued to directly hold a significant number of Maximus shares.
MAXIMUS, Inc. insider equity award activity is reported for the company’s Chief Financial Officer. On December 2, 2025, the officer acquired 13,391.387 shares of common stock at $0 per share following the release of previously granted performance stock units. This amount includes 414.003 shares from dividend equivalent rights tied to those units.
On the same date, the officer surrendered 6,039.515 shares of common stock at a price of $86.51 per share to cover withholding taxes related to the award. After these transactions, the officer directly owned 39,036.754 shares of MAXIMUS common stock.
MAXIMUS, INC. officer equity award vests and shares withheld for taxes. A company officer, General Manager - Health & Human, reported the release of 7,647.465 shares of common stock on 12/02/2025 from previously granted performance stock units. This amount includes 236.401 shares from dividend equivalent rights on the performance stock units granted on November 25, 2022.
The officer then surrendered 3,831.38 shares at a price of $86.51 per share to cover withholding taxes related to the award’s release. After these transactions, the officer beneficially owns 25,392.859 shares of MAXIMUS common stock directly.
Maximus, Inc. officer Theresa D. Golinvaux, Principal Accounting Officer, reported equity transactions in company common stock. On 12/02/2025, she acquired 1,200.769 shares of common stock at $0 upon the release of performance stock units granted on November 25, 2022, including 37.131 shares from dividend equivalent rights. On the same date, she surrendered 541.547 shares at $86.51 to cover withholding taxes tied to the PSU release. After these transactions, she beneficially owns 13,487.77 shares of Maximus common stock directly.
Maximus, Inc. officer Michelle Link, Chief of Human Resources, reported several stock transactions. On 12/02/2025, she acquired 7,358.338 shares of common stock at $0 from the release of performance stock units granted on November 25, 2022, including 227.500 shares from dividend equivalents. On the same day, she surrendered 3,318.61 shares at $86.51 to cover withholding taxes related to this PSU release. On 12/03/2025, she sold 4,039 shares at $86.84, under a Rule 10b5-1 trading plan adopted on December 6, 2024. After these transactions, she directly owned 19,541.801 shares of Maximus common stock.
MAXIMUS, INC. director reported a change in ownership involving a gift of company stock. On 12/01/2025, the reporting person made a gift of 12,000 shares of common stock that had been held indirectly in a trust. The transaction is coded as a gift and shows no sale price, indicating it was a transfer without consideration. After this transaction, the reporting person beneficially owns 55,500 shares of MAXIMUS common stock indirectly through a trust. This filing records the updated ownership position but does not reflect an open-market purchase or sale.
Maximus, Inc. reported an equity compensation-related share increase for a senior executive. Chief Legal Officer John T. Martinez acquired 32.937 shares of Maximus common stock on 12/01/2025. The shares reflect dividend equivalent rights that accrued on previously awarded restricted stock units, with each right equal in value to one share of Maximus common stock and vesting proportionately with the related RSUs. Following this transaction, Martinez directly beneficially owns 22,641.129 shares of Maximus common stock.
Maximus, Inc. reported an insider equity update for its Chief Financial Officer, who filed individually. On 12/01/2025, the officer acquired 36.924 shares of common stock at a price of $0. These were dividend equivalent rights that accrued on previously awarded restricted stock units, and they vest proportionately with the underlying RSUs. Following this transaction, the officer beneficially owns 31,684.882 shares of Maximus common stock in direct ownership form.
Maximus, Inc. director Jan Madsen reported a small increase in her direct ownership of the company’s common stock. On 12/01/2025, she acquired 50.14 shares of Maximus common stock at a price of $0 per share, bringing her total directly held position to 18,256.603 shares after the transaction. The filing explains that these shares relate to dividend equivalent rights that accrued on previously awarded restricted stock units, with each right providing the economic value of one share of Maximus common stock and vesting in step with the underlying restricted stock units.
Maximus, Inc. director Gayathri Rajan reported routine share increases in Maximus common stock. On 11/28/2025, the director acquired 42.301 shares of common stock at $86.112 per share through dividend reinvestment, bringing the directly held position to 14,387.918 shares. On 12/01/2025, an additional 7.594 dividend equivalent rights were credited at $0 cost, tied to previously granted restricted stock units, increasing the directly held total to 14,395.512 shares. Each dividend equivalent right represents the economic equivalent of one share of Maximus common stock and vests proportionately with the related restricted stock units.
Maximus, Inc. officer Michelle Link, Chief of Human Resources, reported an acquisition of common stock-related rights. On 12/01/2025, she acquired 20.008 dividend equivalent rights tied to previously awarded restricted stock units at a price of $0. After this transaction, she beneficially owned a total of 19,541.073 shares of Maximus common stock in direct ownership form. These dividend equivalent rights are described as economically equivalent to one share of Maximus common stock each and vest proportionately with the related restricted stock units.
Maximus, Inc. director reports small stock accrual tied to RSUs. A director of Maximus, Inc. acquired 104.144 shares of common stock on 12/01/2025 at a price of $0. These shares represent dividend equivalent rights that accrued on previously awarded restricted stock units, and each right is the economic equivalent of one share of Maximus common stock.
After this transaction, the director beneficially owns 39,971.489 shares directly. In addition, the director reports indirect ownership of 71,132 shares through the John J. Haley Grantor Retained Annuity Trust Seven and 32,764 shares through the John J. Haley Grantor Retained Annuity Trust Six.
Maximus, Inc. director Raymond B. Ruddy reported an automatic equity-related transaction involving the company’s common stock. On 12/01/2025, he acquired 693.707 shares of Maximus common stock at a price of $0. These were credited as dividend equivalent rights tied to previously awarded restricted stock units, meaning each right is economically equivalent to one share of Maximus common stock and vests proportionately with the underlying RSUs.
Following this transaction, Ruddy beneficially owned a total of 315,939.624 shares of Maximus common stock in direct form. The filing indicates this was a routine update of his holdings and does not involve any sale of shares.
Maximus, Inc. principal accounting officer Theresa D. Golinvaux reported a small increase in her ownership of Maximus common stock. On 12/01/2025, she acquired 14.335 shares of common stock at a price of $0 per share, reflecting dividend equivalent rights tied to previously granted restricted stock units. After this transaction, she beneficially owns 12,828.548 shares directly. Each dividend equivalent right is described as the economic equivalent of one share of Maximus common stock and vests proportionately with the related restricted stock units.
Maximus, Inc. disclosed that officer Ilene Baylinson acquired additional common stock-related rights through dividend equivalents on restricted stock units. On 12/01/2025, she received 27.639 dividend equivalent rights, each economically equivalent to one share of Maximus common stock, at a price of $0 as part of her existing equity awards. Following this transaction, she beneficially owned 21,576.774 shares of common stock in direct ownership, reflecting accumulated equity compensation rather than an open-market purchase.
Maximus, Inc. director Michael J. Warren reported small increases in his company stock holdings. On 11/28/2025, he acquired 14.403 shares of Maximus common stock at a price of $86.111 per share, marked as a purchase. On 12/01/2025, he received an additional 39.07 shares with a stated price of $0 per share.
After these transactions, Warren beneficially owned 15,524.345 shares of Maximus common stock directly. The filing explains that the first transaction reflects shares purchased through a dividend reinvestment program, while the second represents dividend equivalent rights credited on previously awarded restricted stock units, each equivalent in value to one share of Maximus common stock.
Maximus, Inc. director Anne K. Altman reported an automatic acquisition of common stock linked to previously granted restricted stock units. On 12/01/2025, she acquired 10.632 shares of Maximus common stock at a price of $0 as dividend equivalent rights, which accrue on existing restricted stock units and vest in step with those awards. Following this transaction, she beneficially owned a total of 32,066.067 shares in direct form. Each dividend equivalent right is described as economically equivalent to one share of Maximus common stock.
Maximus, Inc. (MMS) filed a Form 4 reporting equity transactions by its Chief Financial Officer, David Mutryn. On 11/24/2025, he received 10,259 restricted stock units (RSUs) of Maximus common stock at a price of $0, increasing his direct beneficial ownership to 35,647.958 shares.
The RSUs vest ratably over three years on 09/30/2026, 09/30/2027, and 09/30/2028, with the possibility of deferred vesting under the award terms. On the same day, he made a gift of 4,000 shares of common stock to a charitable donor advised fund, reducing his direct beneficial ownership to 31,647.958 shares.
Maximus, Inc. (MMS) reported an equity award to its Chief Legal Officer on a Form 4. On 11/24/2025, the officer received 7,409 shares of common stock in the form of restricted stock units (RSUs) at a stated price of $0, reflecting a compensation grant rather than an open‑market purchase. After this grant, the officer beneficially owned 22,608.192 shares directly.
The RSUs vest in three equal annual installments on 09/30/2026, 09/30/2027, and 09/30/2028, with the ability to elect deferred vesting for a longer period as permitted by the award terms. Each RSU represents a contingent right to receive one share of Maximus common stock, aligning the executive’s compensation with the company’s equity over a multi‑year period.
MAXIMUS, Inc. (MMS) reported an equity award to a company officer on a Form 4. General Manager – Health & Human, Ilene Baylinson, received a grant of 7,409 restricted stock units (RSUs) of MAXIMUS common stock on 11/24/2025 at a stated price of $0, reflecting the nature of the award rather than a market purchase.
The RSUs vest in three equal annual installments on 09/30/2026, 09/30/2027, and 09/30/2028, subject to possible deferred vesting at the individual’s election as permitted by the award terms. Each RSU represents a contingent right to receive one share of common stock. Following this grant, Baylinson beneficially owns 21,549.135 shares of MAXIMUS common stock in direct ownership.
MAXIMUS, Inc. (MMS) reported a Form 4 transaction for its Chief of Human Resources, Michelle Link. On 11/24/2025, she received a grant of 6,013 restricted stock units (RSUs) of MAXIMUS common stock at a price of $0, reflecting an equity award rather than a purchase.
Following this grant, she beneficially owned 19,521.065 shares of MAXIMUS common stock in direct ownership. The RSUs vest on a three-year ratable schedule, with vesting dates on 09/30/2026, 09/30/2027, and 09/30/2028, and may be deferred for a longer period if elected under the award terms. Each RSU represents a contingent right to receive one share of common stock.
MAXIMUS, Inc. (MMS) reported an equity award to a senior executive. Principal Accounting Officer Theresa D. Golinvaux received a grant of 2,565 restricted stock units (RSUs) of common stock on 11/24/2025 at a price of $0 per share. These RSUs are scheduled to vest in four equal annual installments on 09/30/2026, 09/30/2027, 09/30/2028, and 09/30/2029, with the possibility of deferred vesting at her election under the award terms. After this grant, she beneficially owns 12,814.213 shares of MAXIMUS common stock in total.
Theresa D. Golinvaux, listed as Principal Accounting Officer of MAXIMUS, Inc. (MMS), reported a transaction dated 09/30/2025 on a Form 4. The filing shows 1,206.759 shares of common stock were disposed of at a price of $91.37; the form explains these shares were surrendered to satisfy withholding tax related to the vesting of restricted stock units (RSUs). After the reported disposition, the reporting person beneficially owns 10,249.213 shares, which includes previously reported RSU awards totaling 5,628.387 RSUs and accrued dividend equivalents with varying distribution schedules. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 10/02/2025.
Michelle Link, Chief of Human Resources at MAXIMUS, Inc. (MMS), reported changes in beneficial ownership on a Form 4. On 09/30/2025 she surrendered 2,255.654 shares to satisfy withholding taxes from vested restricted stock units at a price of $91.37, leaving 15,118.065 shares reported immediately after that transaction. On 10/01/2025 she sold 1,610 shares at $90.86, reducing her reported beneficial ownership to 13,508.065 shares. The filing notes prior RSU awards representing 8,551.266 RSUs with dividend equivalents previously reported and that the sales on 10/01/2025 were executed under a 10b5-1 trading plan adopted on 12/06/2024. The Form is signed by an attorney-in-fact on behalf of the reporting person on 10/02/2025.
John T. Martinez, Chief Legal Officer of MAXIMUS, Inc. (MMS), reported a transaction dated 09/30/2025 disposing of 3,017.119 shares of common stock at $91.37 per share. The filing explains those shares were surrendered to satisfy withholding tax from the vesting of restricted stock units (RSUs). After the reported transaction the reporting person beneficially owns 15,199.192 shares, which includes 13,230.101 previously reported RSUs and accrued dividend equivalent rights with varying distribution schedules.